BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/15/2020 12:32:18 PM | Browse: 1248 | Download: 2004
 |
Received |
|
2019-10-07 16:32 |
|
Peer-Review Started |
|
2019-10-07 16:33 |
|
First Decision by Editorial Office Director |
|
2019-10-18 15:45 |
|
Return for Revision |
|
2019-10-21 08:31 |
|
Revised |
|
2019-10-29 23:06 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-01-05 08:50 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-01-07 05:09 |
|
Articles in Press |
|
2020-01-07 05:09 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-01-16 09:58 |
|
Publish the Manuscript Online |
|
2020-02-15 12:32 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Observational Study |
| Article Title |
Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Karen Kaiser, Madison Lyleroehr, Sara Shaunfield, Leilani Lacson, Maria Corona, Sheetal Kircher, Malin Nittve and David Cella |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Karen Kaiser, PhD, Associate Professor, Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, 625 N Michigan Ave, Suite 2700, Chicago, IL 60611, United States. k-kaiser@northwestern.edu |
| Key Words |
Neuropathy; Colorectal cancer; Patient reported outcomes; Quality of life; ; |
| Core Tip |
Colorectal cancer patients report significant impairment in dexterity, mobility, and balance due to neuropathy. Because prevention and treatment options for oxaliplatin-induced neuropathy are limited ongoing monitoring and management of neuropathy is important for patient quality of life and treatment adherence. A validated self-reported measure of neuropathy would aid in the management and assessment of neuropathy. This study examined the content validity of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale for colorectal patients with oxaliplatin-induced neuropathy; the measure was found to have content validity for this population. |
| Publish Date |
2020-02-15 12:32 |
| Citation |
Kaiser K, Lyleroehr M, Shaunfield S, Lacson L, Corona M, Kircher S, Nittve M, Cella D. Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale. World J Gastrointest Oncol 2020; 12(2): 205-218 |
| URL |
https://www.wjgnet.com/1948-5204/full/v12/i2/205.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v12.i2.205 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
